In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases

BACKGROUND: Acinetobacter baumannii has emerged as a major nosocomial pathogen worldwide. Many of the circulating strains exhibit multi-drug resistance remaining consistently susceptible only to polymyxins. In-vitro studies have reported that polymyxins combined with carbapenems, rifampicin or azith...

Descripción completa

Detalles Bibliográficos
Autores principales: Wareham, David W, Bean, David C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1484489/
https://www.ncbi.nlm.nih.gov/pubmed/16630352
http://dx.doi.org/10.1186/1476-0711-5-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1484489/
https://www.ncbi.nlm.nih.gov/pubmed/16630352
http://dx.doi.org/10.1186/1476-0711-5-10

Ejemplares similares